Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enovis (ENOV) EBT (2016 - 2025)

Enovis (ENOV) has disclosed EBT for 16 consecutive years, with -$509.5 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 24.37% to -$509.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a 40.89% decrease, with the full-year FY2025 number at -$1.2 billion, down 40.89% from a year prior.
  • EBT was -$509.5 million for Q4 2025 at Enovis, up from -$566.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $116.4 million in Q3 2022 to a low of -$673.7 million in Q4 2024.
  • A 5-year average of -$116.5 million and a median of -$33.8 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: soared 401.46% in 2023, then crashed 8898.82% in 2024.
  • Enovis' EBT stood at -$247.4 million in 2021, then skyrocketed by 98.97% to -$2.5 million in 2022, then skyrocketed by 401.46% to $7.7 million in 2023, then plummeted by 8898.82% to -$673.7 million in 2024, then increased by 24.37% to -$509.5 million in 2025.
  • Per Business Quant, the three most recent readings for ENOV's EBT are -$509.5 million (Q4 2025), -$566.9 million (Q4 2025), and -$25.7 million (Q3 2025).